Drug‐induced liver injury (DILI) is the most frequent cause of post‐marketing warnings and
withdrawals. Amiodarone (AMD), an antiarrhythmic, presents a risk of liver injury in humans …

Aims To compare the frequencies of adverse drug reactions (ADRs) to amiodarone from
three separate datasets:(i) a meta‐analysis of clinical trials,(ii) spontaneous reports …

Purpose The main aim of this study was to determine the most frequently reported drugs to
the Serbian Pharmacovigilance Database (SPD) with suspected induced hepatotoxicity …

The prevalence of apparent amiodarone-related hepatic injury in 104 patients followed
prospectively is compared to that reported in the literature. Asymptomatic elevation of serum …

Background Most clinical trials that support approval are not adequately powered to detect
rare adverse reactions (eg, drug-induced liver injury, Stevens–Johnson syndrome, and …

Background: Hepatotoxicity due to intravenous amiodarone (HIVAD) is a rare side effect with
a distinct pattern of enzyme disturbances compared to liver damage from oral amiodarone …

The anti-arrhythmic agent amiodarone (AD) is associated with numerous adverse effects,
but serious liver disease is rare. The improved safety of administration of daily low doses of …

Amiodarone is a class III antiarrhythmic drug widely used for the treatment of both
supraventricular and ventricular arrhythmias in intensive care unit. Hepatotoxicity of …

Introduction Amiodarone can induced hepatic dysfunction. Observations We describe two
patients who developed hepatotoxicity presenting suggestive histological features. The …

Amiodarone is a class III antiarrhythmic agent that inhibits adrenergic stimulation by blocking
alpha and beta receptors. It prolongs action potential and refractory period in myocardial …